Ouchveridze, Evguenia
Banerjee, Rahul http://orcid.org/0000-0003-3781-5441
Desai, Aakash
Aziz, Muhammad
Lee-Smith, Wade
Mian, Hira http://orcid.org/0000-0003-1584-1067
Berger, Katherine
McClune, Brian
Sborov, Douglas http://orcid.org/0000-0003-4268-2698
Qazilbash, Muzaffar http://orcid.org/0000-0003-2876-2886
Kumar, Shaji http://orcid.org/0000-0001-5392-9284
Mohyuddin, Ghulam Rehman http://orcid.org/0000-0001-6464-783X
Article History
Received: 17 January 2022
Revised: 6 April 2022
Accepted: 8 April 2022
First Online: 22 April 2022
Competing interests
: RB reports consulting from Guidepoint Global, Sanofi, SparkCures; institutional research funding from Pack Health; and honoraria from Curio Science. SK reports consulting/advisory board participation and personal payment from Oncopeptides, Genecentrix and Cellectar. HSM has received consultancy fees and/or honoraria from Celgene, Takeda, Janssen, Amgen, and Sanofi. DS reports consulting for Janssen, Sanofi, GlaxoSmithKline, Bristol Myers Squibb. The remaining authors declare no competing interests.